Nomura Asset Management
HZNP

Nomura Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nomura Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-51,730
Closed -$5.98M – 1569
2023
Q3 		$5.98M Sell
51,730
-590
-1% -$63.4K 0.03% 455
2023
Q2 		$5.38M Hold
52,320
– – 0.02% 490
2023
Q1 		$5.71M Buy
52,320
+1,547
+3% +$171K 0.03% 456
2022
Q4 		$5.78M Buy
50,773
+2,853
+6% +$237K 0.03% 438
2022
Q3 		$2.97M Hold
47,920
– – 0.02% 565
2022
Q2 		$3.82M Buy
47,920
+2,625
+6% +$249K 0.02% 515
2022
Q1 		$4.77M Buy
45,295
+3,112
+7% +$303K 0.03% 497
2021
Q4 		$4.55M Buy
42,183
+1,142
+3% +$125K 0.02% 519
2021
Q3 		$4.5M Sell
41,041
-3,020
-7% -$314K 0.03% 490
2021
Q2 		$4.13M Buy
44,061
+5,071
+13% +$467K 0.02% 530
2021
Q1 		$3.59M Buy
38,990
+500
+1% +$42.2K 0.02% 544
2020
Q4 		$2.82M Buy
+38,490
New +$2.86M 0.02% 583

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nomura Asset Management's HZNP Position: Q4 2023 in Review

Nomura Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 51,730 shares — an estimated $5.98M sold.

Nomura Asset Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $5.98M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Nomura Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Nomura Asset Management sold 51,730 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.98M.
  • Nomura Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
  • Nomura Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $5.98M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nomura Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.